Media Summary: ... what we were attempting to do with the Friends of Cancer Research Annual Meeting 2025 will spotlight pressing topics at the forefront of cancer research and regulation, ... Learn the essential principles behind rigorous clinical research that supports FDA drug approvals. This video covered the key ...

Session 2 Trial Design For - Detailed Analysis & Overview

... what we were attempting to do with the Friends of Cancer Research Annual Meeting 2025 will spotlight pressing topics at the forefront of cancer research and regulation, ... Learn the essential principles behind rigorous clinical research that supports FDA drug approvals. This video covered the key ... This lecture is part of the NIH Clinical and Translational Research Summer Course which provides an online opportunity for ... Jörn Schattenberg and Naim Alkhouri join the Surfers (including NASH-TAG co-director Stephen Harrison) to review NASH-TAG ... Justin Presseau, Scientist, Clinical Epidemiology Program Ottawa Hospital Research Institute and Assistant Professor, School of ...

The Critical Path Institute's International Neonatal Consortium (INC) is a global collaboration formed to forge a predictable ...

Photo Gallery

Session 2: Trial design for psychedelic assisted therapies – Panel discussion and Q&A
Session 2: Trial design for psychedelic assisted therapies – Presentation
Session 2: Trial Designs for Combination Drug Development
SBS Day 2 - Session IV: Clinical Trial Design Considerations
Phase II Study Design for Tivantinib in Breast Cancer
CITC 2024 – D1S02 – Basics of Clinical Trial Design
Adaptive Trial Designs - Alex Kaizer @  ERD Conference 6.5.19
Presentation 2B - Study Design Part 1 - Randomized Clinical Trials - Mike Proschan
S2-E12 - NASH-TAG Session 2 Summary: Innovative Trial Design and Robust Histologic Analyses
Module 02   Trial Design and Regulatory Strategy
Phase 1 and 2 Trial Design by Donald Jensen and Panel Discussion
Workshop: Working with Patients to Inform Early Phase Clinical Trial Design (Part 2)
View Detailed Profile
Session 2: Trial design for psychedelic assisted therapies – Panel discussion and Q&A

Session 2: Trial design for psychedelic assisted therapies – Panel discussion and Q&A

... what we were attempting to do with the

Session 2: Trial design for psychedelic assisted therapies – Presentation

Session 2: Trial design for psychedelic assisted therapies – Presentation

... the

Session 2: Trial Designs for Combination Drug Development

Session 2: Trial Designs for Combination Drug Development

Friends of Cancer Research Annual Meeting 2025 will spotlight pressing topics at the forefront of cancer research and regulation, ...

SBS Day 2 - Session IV: Clinical Trial Design Considerations

SBS Day 2 - Session IV: Clinical Trial Design Considerations

Session

Phase II Study Design for Tivantinib in Breast Cancer

Phase II Study Design for Tivantinib in Breast Cancer

David Liu, MD, PhD.

CITC 2024 – D1S02 – Basics of Clinical Trial Design

CITC 2024 – D1S02 – Basics of Clinical Trial Design

Learn the essential principles behind rigorous clinical research that supports FDA drug approvals. This video covered the key ...

Adaptive Trial Designs - Alex Kaizer @  ERD Conference 6.5.19

Adaptive Trial Designs - Alex Kaizer @ ERD Conference 6.5.19

Adaptive Clinical

Presentation 2B - Study Design Part 1 - Randomized Clinical Trials - Mike Proschan

Presentation 2B - Study Design Part 1 - Randomized Clinical Trials - Mike Proschan

This lecture is part of the NIH Clinical and Translational Research Summer Course which provides an online opportunity for ...

S2-E12 - NASH-TAG Session 2 Summary: Innovative Trial Design and Robust Histologic Analyses

S2-E12 - NASH-TAG Session 2 Summary: Innovative Trial Design and Robust Histologic Analyses

Jörn Schattenberg and Naim Alkhouri join the Surfers (including NASH-TAG co-director Stephen Harrison) to review NASH-TAG ...

Module 02   Trial Design and Regulatory Strategy

Module 02 Trial Design and Regulatory Strategy

Explore clinical

Phase 1 and 2 Trial Design by Donald Jensen and Panel Discussion

Phase 1 and 2 Trial Design by Donald Jensen and Panel Discussion

Session 2

Workshop: Working with Patients to Inform Early Phase Clinical Trial Design (Part 2)

Workshop: Working with Patients to Inform Early Phase Clinical Trial Design (Part 2)

Justin Presseau, Scientist, Clinical Epidemiology Program Ottawa Hospital Research Institute and Assistant Professor, School of ...

INC 2020 Workshop: Trial Design & Execution Session

INC 2020 Workshop: Trial Design & Execution Session

The Critical Path Institute's International Neonatal Consortium (INC) is a global collaboration formed to forge a predictable ...